GlassScriptPhysician profile
Elysha Dinh
NPI 1508213927
$7,539.05
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,118 · 2021: $111 · 2022: $958 · 2023: $932 · 2024: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $5,031.17 | 2020 | |
| Medtronic, INC. | $826.70 | 2021-2024 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Abbott Laboratories | $620.72 | 2022-2023 | Proclaim |
| Boston Scientific Corporation | $410.73 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $307.33 | 2022-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $91.38 | 2021-2022 | |
| Relievant Medsystems, INC. | $91.27 | 2022 | |
| Bioventus LLC | $86.75 | 2022 | |
| Abbvie INC. | $24.17 | 2023 | Botox |
| Pacira Pharmaceuticals Incorporated | $22.87 | 2024 | Exparel |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Spr Therapeutics, INC | $8.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elysha Dinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.